Wells Fargo Starts OncoMed Pharmaceuticals (OMED) at Outperform
Tweet Send to a Friend
Wells Fargo initiated coverage on OncoMed Pharmaceuticals (NASDAQ: OMED) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


